¼¼°èÀÇ Æ÷µµ´ç ºÎÇÏ ½ÃÇè ½ÃÀå : Á¦Ç° À¯Çüº°, ÀûÀÀ Áúȯº°, ÃÖÁ¾»ç¿ëÀÚº°, ±¹°¡º°, Áö¿ªº° - »ê¾÷ ºÐ¼®, ½ÃÀå ±Ô¸ð ¹× Á¡À¯À², ¿¹Ãø(2024-2032³â)
Glucose Tolerance Test Market, By Product Type, By Disease Indication, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
»óǰÄÚµå : 1629212
¸®¼­Ä¡»ç : AnalystView Market Insights
¹ßÇàÀÏ : 2024³â 12¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 288 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,250 £Ü 4,590,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç, ÅØ½ºÆ®ÀÇ Copy&Pasteµµ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 4,650 £Ü 6,568,000
PDF (5 User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 5,650 £Ü 7,980,000
PDF & Excel (Enterprise User License) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ³» ¸ðµç »ç¿ëÀÚ°¡ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy&Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¸®Æ÷Æ® ÇÏÀ̶óÀÌÆ®

Æ÷µµ´ç ºÎÇÏ ½ÃÇè ½ÃÀå ±Ô¸ð´Â 2023³â¿¡ 269¾ï 2,043¸¸ ´Þ·¯¿¡ ´ÞÇϸç, 2024-2032³â¿¡ CAGR 6.60%·Î È®´ë

Æ÷µµ´ç ºÎÇÏ Å×½ºÆ® ½ÃÀå ¿ªÇÐ

Àü ¼¼°è ´ç´¢º´ À¯º´·ü Áõ°¡·Î ½ÃÀå ¼ö¿ä Áõ°¡ ÃËÁø

Àü ¼¼°è »ç¶÷µé »çÀÌ¿¡¼­ ´ç´¢º´ À¯º´·üÀÌ Áõ°¡Çϰí ÀÖ´Â °ÍÀº ¼¼°è Æ÷µµ´ç ºÎÇÏ Å×½ºÆ® ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿ä ¿äÀÎÀÔ´Ï´Ù. ¿¹¸¦ µé¾î Àü ¼¼°è ´ç´¢º´ À¯º´·üÀº 2021³â 5¾ï 3,700¸¸ ¸í¿¡¼­ 2045³â 7¾ï 8,300¸¸ ¸íÀ¸·Î Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ Àα¸ ¹Ðµµ°¡ ³ôÀº Áö¿ª¿¡¼­ ´ç´¢º´¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö°í ´ë±Ô¸ð Áø´Ü ¼Ö·ç¼Ç ¼³°è ¹× °³¹ß¿¡ ´ëÇÑ ¸·´ëÇÑ ÅõÀÚ°¡ °áÇÕµÇ¾î ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±×·¯³ª Àα¸°¡ ÀûÀº Áö¿ª¿¡¼­´Â ³ôÀº ºñ¿ë°ú Á¦ÇÑµÈ ÀÇ·á ¼­ºñ½º Á¢±Ù¼ºÀ¸·Î ÀÎÇØ ½ÃÀå ¼ºÀå¿¡ °É¸²µ¹ÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù. ¹Ý´ë·Î, Áø´Ü »ê¾÷¿¡¼­ µö·¯´×°ú ·Îº¿°øÇÐÀÇ ÅëÇÕ, ´ç´¢º´ Ä¡·áÁ¦ ¹× Áø´Ü ÀǾàǰ ¿¬±¸°³¹ß¿¡ ´ëÇÑ Á¤ºÎ ÀÚ±Ý Áõ°¡´Â ¿¹Ãø ±â°£ Áß ½ÃÀå¿¡ ´ë±Ô¸ð ¼ºÀå ±âȸ¸¦ Á¦°øÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Æ÷µµ´ç ºÎÇÏ Å×½ºÆ® ½ÃÀå : ÁÖ¿ä °í·Á»çÇ×

´ç»çÀÇ ¸®¼­Ä¡ ¾Ö³Î¸®½ºÆ®µéÀÇ ºÐ¼®¿¡ µû¸£¸é ¼¼°è ½ÃÀåÀº ¿¹Ãø ±â°£(2024-2032³â) µ¿¾È ¾à 6.60%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î ¸Å³â ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Á¦Ç° À¯Çüº°·Î´Â Ç÷´ç °Ë»ç ŰƮ°¡ 2023³â¿¡ °¡Àå ³ôÀº ½ÃÀå Á¡À¯À²À» º¸¿´½À´Ï´Ù.

ÀûÀÀÁõº°·Î´Â ´ç´¢º´¼º ÀúÇ÷´çÀÌ 2023³â ÁÖ¿ä ºÎ¹®À¸·Î ²ÅÇû½À´Ï´Ù.

Áö¿ªº°·Î´Â ºÏ¹Ì Æ÷µµ´ç ºÎÇÏ Å×½ºÆ® ½ÃÀåÀÌ 2023³â ÁÖ¿ä ¼öÀÔ¿øÀÌ µÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Æ÷µµ´ç ºÎÇÏ Å×½ºÆ® ½ÃÀå : ¼¼ºÐÈ­ ºÐ¼®

Æ÷µµ´ç ºÎÇÏ Å×½ºÆ® ¼¼°è ½ÃÀåÀº Á¦Ç° À¯Çü, ÀûÀÀÁõ, ÃÖÁ¾»ç¿ëÀÚ, Áö¿ªÀ» ±âÁØÀ¸·Î ¼¼ºÐÈ­µË´Ï´Ù.

Á¦Ç° À¯Çüº°·Î´Â Ç÷´ç °Ë»ç ŰƮ, ½º¸¶Æ® ¼¾¼­, ÃøÁ¤±â, ±âŸ µî 4°¡Áö·Î ºÐ·ùµË´Ï´Ù. Ç÷´ç °Ë»ç ŰƮ ºÐ¾ß°¡ ½ÃÀåÀ» µ¶Á¡Çϰí ÀÖ½À´Ï´Ù. ½º¸¶Æ® ¼¾¼­ ±â¼úÀÇ ¹ßÀü°ú ¿øÈ°ÇÑ IoT ¿¬°áÀÌ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù.

ÀÌ ½ÃÀåÀº ÃÖÁ¾»ç¿ëÀÚ¿¡ µû¶ó ÀçÅÃÀÇ·á, º´¿ø ¹× Ŭ¸®´Ð, Áø´Ü¼¾ÅÍ, ±âŸ·Î ºÐ·ùµË´Ï´Ù. º´¿ø ¹× Ŭ¸®´Ð ºÎ¹®ÀÌ ½ÃÀåÀ» µ¶Á¡Çϰí ÀÖÀ¸¸ç, ¿¹Ãø ±â°£ Áß¿¡µµ ±× ¿ìÀ§¸¦ À¯ÁöÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ÀÌ´Â ÁÖ·Î º´¿ø/Ŭ¸®´ÐÀÇ È¯ÀÚ ¼ö°¡ ¸¹°í, Á¤È®Çϰí È¿À²ÀûÀÎ Æ÷µµ´ç ºÎÇÏ °Ë»ç¸¦ À§ÇÑ °í±Þ Áø´Ü ÅøÀÌ Á¦°øµÇ±â ¶§¹®ÀÔ´Ï´Ù.

Æ÷µµ´ç ºÎÇÏ Å×½ºÆ® ½ÃÀå : Áö¿ªº° ºÐ¼®

Áö¿ªÀûÀ¸·Î ÀÌ ½ÃÀåÀº ºÏ¹Ì, ¶óƾ¾Æ¸Þ¸®Ä«, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«¿¡ °ÉÃÄ ÀÖ½À´Ï´Ù. ÀÌ Áö¿ªÀº ºñÁî´Ï½º¸¦ °¡Á® ¿À´Â ±¹°¡¿¡ µû¶ó ´õ ¼¼ºÐÈ­µË´Ï´Ù.

Æ÷µµ´ç ºÎÇÏ Å×½ºÆ® ½ÃÀå : °æÀï ±¸µµ

ÀÌ ½ÃÀåÀº ´ç´¢º´ Á¶±â ¹ß°ß¿¡ ´ëÇÑ Àνİú ³ë·Â Áõ°¡·Î ÀÎÇØ ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. ±â¾÷Àº Àü·«Àû Á¦ÈÞ¸¦ ÅëÇØ ¿¬±¸¸¦ °­È­Çϰí ÷´Ü Áø´Ü ¼Ö·ç¼ÇÀ» °³¹ßÇϱâ À§ÇØ ³ë·ÂÇϰí ÀÖ½À´Ï´Ù. °æÀï·ÂÀ» À¯ÁöÇϱâ À§ÇØ °¢ ¾÷üµéÀº ´õ ³ªÀº Ç÷´ç ¸ð´ÏÅ͸µÀ» À§ÇØ µðÁöÅÐ Çコ ÅëÇÕ°ú °°Àº ÷´Ü ±â¼ú¿¡ ÅõÀÚÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ M&A¸¦ ÅëÇØ Á¦Ç° ¶óÀÎÀÇ ´Ù¾çÈ­¿Í ¹Ì°³Ã´ ½ÃÀå ÁøÃâÀ» Áö¿øÇϰí, Àü¹ÝÀûÀÎ °æÀï·Â°ú ½ÃÀå ¿µÇâ·ÂÀ» ³ôÀ̱â À§ÇØ M&A¸¦ ÅëÇØ ¼¼°è ÀÔÁö¸¦ È®´ëÇÏ´Â °ÍÀÌ Áß¿äÇÑ ÃÊÁ¡ÀÌ µÇ°í ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Æ÷µµ´ç ºÎÇÏ ½ÃÇè ½ÃÀå °³¿ä

Á¦2Àå °³¿ä

Á¦3Àå Æ÷µµ´ç ºÎÇÏ ½ÃÇèÀÇ ÁÖ¿ä ½ÃÀå µ¿Çâ

Á¦4Àå Æ÷µµ´ç ºÎÇÏ ½ÃÇè ½ÃÀå : »ê¾÷ ºÐ¼®

Á¦5Àå Æ÷µµ´ç ºÎÇÏ ½ÃÇè ½ÃÀå : ³ô¾ÆÁö´Â ÁöÁ¤ÇÐÀû ±äÀåÀÇ ¿µÇâ

Á¦6Àå Æ÷µµ´ç ºÎÇÏ ½ÃÇè ½ÃÀå ±¸µµ

Á¦7Àå Æ÷µµ´ç ºÎÇÏ ½ÃÇè ½ÃÀå : Á¦Ç° À¯Çüº°

Á¦8Àå Æ÷µµ´ç ºÎÇÏ ½ÃÇè ½ÃÀå : ÀûÀÀ Áúȯº°

Á¦9Àå Æ÷µµ´ç ºÎÇÏ ½ÃÇè ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

Á¦10Àå Æ÷µµ´ç ºÎÇÏ ½ÃÇè ½ÃÀå : Áö¿ªº°

Á¦11Àå ÁÖ¿ä º¥´õ ºÐ¼® : Æ÷µµ´ç ºÎÇÏ ½ÃÇè ¾÷°è

Á¦12Àå AnalystViewÀÇ Àü¹æÀ§Àû ºÐ¼®

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

REPORT HIGHLIGHT

Glucose tolerance test market size was valued at USD 26,920.43 Million in 2023, expanding at a CAGR of 6.60% from 2024 to 2032.

A glucose tolerance test (GTT) is a diagnostic tool used to evaluate the body's response to sugar intake, primarily for diagnosing diabetes. It includes an oral glucose tolerance test (OGTT), where blood glucose levels are measured before and after consuming a glucose solution. High glucose levels may indicate impaired sugar absorption by body cells. A simpler version, the glucose challenge test, involves a single blood test following glucose intake.

Glucose Tolerance Test Market- Market Dynamics

Increasing rate of diabetes worldwide to propel market demand

The growing prevalence of diabetes among people across the globe is the major factor driving the growth of the global glucose tolerance test market. For instance, the global incidence of diabetes is expected to rise to 783 million by 2045, up from 537 million in 2021. Besides, increasing awareness of diabetes mellitus in densely populated regions, combined with significant investments in the design and development of large-scale diagnostic solutions, is expected to fuel market growth. However, high costs and restricted access to medical services in underdeveloped regions may hamper the market growth. On the contrary, the integration of deep learning and robotics in the diagnostic industry and increased government funding for research and development in diabetes therapeutics & diagnostics are predicted to provide massive growth opportunities for the market during the forecast period.

Glucose Tolerance Test Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 6.60% over the forecast period (2024-2032)

Based on product type segmentation, blood glucose test kit was predicted to show maximum market share in the year 2023

Based on disease indication segmentation, diabetes hypoglycemia was the leading segment in 2023

On the basis of region, the North America glucose tolerance test market was the leading revenue generator in 2023

Glucose Tolerance Test Market- Segmentation Analysis:

The Global Glucose Tolerance Test Market is segmented on the basis of Product Type, Disease Indication, End User, and Region.

The market is divided into four categories based on product type: blood glucose testing kit, smart sensors, meters, and others. The blood glucose testing kit sector dominates the market. Advancements in smart sensor technology and seamless IoT connectivity are driving the market growth.

The market is divided into two categories based on end user: homecare settings, hospitals & clinics, diagnostic centers, and others. The hospitals & clinics sector dominates the market and is likely to maintain its dominance during the forecast period. This is mainly due to the high patient volume they handle and the availability of advanced diagnostic tools for accurate and efficient glucose tolerance testing.

Glucose Tolerance Test Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Glucose Tolerance Test Market- Competitive Landscape:

The market is propelled by growing awareness and efforts for early diabetes detection. Companies are prioritizing strategic collaborations to enhance research and develop advanced diagnostic solutions. To stay competitive, players are investing in cutting-edge technologies, like digital health integration, for better glucose monitoring. Additionally, expanding global presence through mergers and acquisitions is a key focus, as it helps diversify product lines and reach untapped markets, boosting their overall competitiveness and market influence.

Recent Developments:

In August 2024, DirectSens has introduced the XpressGT RUO kit for diagnosing conditions like Gestational Diabetes, Endometriosis, Insulin Resistance, and Liver Disease. Compatible with standard clinical analyzers, XpressGT provides results in just 8 minutes, measuring 2-hydroxybutyrate (2-HB) levels in venous blood, which, when elevated, indicate potential endocrine and metabolic disorders.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL GLUCOSE TOLERANCE TEST MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

GLOBAL GLUCOSE TOLERANCE TEST MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

GLOBAL GLUCOSE TOLERANCE TEST MARKET, BY DISEASE INDICATION- MARKET ANALYSIS, 2019 - 2032

GLOBAL GLUCOSE TOLERANCE TEST MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

GLOBAL GLUCOSE TOLERANCE TEST MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

Table of Contents

1. Glucose Tolerance Test Market Overview

2. Executive Summary

3. Glucose Tolerance Test Key Market Trends

4. Glucose Tolerance Test Industry Study

5. Glucose Tolerance Test Market: Impact of Escalating Geopolitical Tensions

6. Glucose Tolerance Test Market Landscape

7. Glucose Tolerance Test Market - By Product Type

8. Glucose Tolerance Test Market - By Disease Indication

9. Glucose Tolerance Test Market - By End User

10. Glucose Tolerance Test Market- By Geography

11. Key Vendor Analysis- Glucose Tolerance Test Industry

12. 360 Degree Analyst View

13. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â